M-alpha-HMCA
Appearance
This article needs additional citations for verification. (June 2020) |
![]() | |
Identifiers | |
---|---|
| |
Chemical and physical data | |
Formula | C13H18N2O4 |
Molar mass | 266.13 g/mol (freebase) 239.78 g/mol (hydrochloride) g·mol−1 |
3D model (JSmol) | |
| |
|
M-alpha-HMCA (3-(benzo[d][1,3]dioxol-5-yl)-2-hydroxy-N,2-dimethyl-3-(methylamino)propanamide) is an unintentional sideproduct during the synthesis of MDMA using PMK glycidate as a precursor. It was identified in MDMA pills.[1] The biological properties of this molecule have not yet been documented. The backbone of the chemical structure is M-alpha whose psychoactive activity has been described by Alexander Shulgin.[citation needed]
References
[edit]- ^ Lee JH, Park OR, Mandava S, Kim J, Koo J, Lee J, Kang H (August 2020). "Identification of a new M-ALPHA analog and MDMA in an illegal health product". Forensic Science International. 313: 110332. doi:10.1016/j.forsciint.2020.110332. PMID 32540761.